Base de dados : MEDLINE
Pesquisa : C13.351 [Categoria DeCS]
Referências encontradas : 1916 [refinar]
Mostrando: 1 .. 10   no formato [Detalhado]

página 1 de 192 ir para página                         

  1 / 1916 MEDLINE  
              next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29406065
[Au] Autor:Manjunath AS; Hofer MD
[Ad] Endereço:Department of Urology, Northwestern University Feinberg School of Medicine, 303 East Chicago Avenue 16-703, Chicago, IL 60611, USA.
[Ti] Título:Urologic Emergencies.
[So] Source:Med Clin North Am;102(2):373-385, 2018 Mar.
[Is] ISSN:1557-9859
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Urologic emergencies can involve the kidneys, ureters, bladder, urethra, penis, scrotum, or testicles. History and physical examination are essential to diagnosis, whereas imaging is increasingly used to confirm diagnoses. Acute urinary retention should be relieved with Foley placement. Penile emergencies include paraphimosis, which can be treated by foreskin reduction, whereas penile fracture and priapism require urologic intervention. Fournier gangrene and testicular torsion are scrotal emergencies requiring emergent surgery. Nephrolithiasis, although painful, is not an emergency unless there is concern for concomitant urinary tract infection, both ureters are obstructed by stones, or there is an obstructing stone in a solitary kidney.
[Mh] Termos MeSH primário: Doenças Urológicas/diagnóstico
Doenças Urológicas/terapia
[Mh] Termos MeSH secundário: Doença Aguda
Emergências
Feminino
Doenças Urogenitais Femininas/diagnóstico
Doenças Urogenitais Femininas/terapia
Gangrena de Fournier/diagnóstico
Gangrena de Fournier/terapia
Seres Humanos
Masculino
Doenças Urogenitais Masculinas/diagnóstico
Doenças Urogenitais Masculinas/terapia
Nefrolitíase/diagnóstico
Nefrolitíase/microbiologia
Nefrolitíase/terapia
Parafimose/diagnóstico
Parafimose/terapia
Pênis/lesões
Priapismo/diagnóstico
Priapismo/terapia
Encaminhamento e Consulta
Ruptura
Torção do Cordão Espermático/diagnóstico
Torção do Cordão Espermático/terapia
Retenção Urinária/diagnóstico
Retenção Urinária/terapia
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180208
[Lr] Data última revisão:
180208
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:180207
[St] Status:MEDLINE


  2 / 1916 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29281731
[Au] Autor:Nyari S; Waugh CA; Dong J; Quigley BL; Hanger J; Loader J; Polkinghorne A; Timms P
[Ad] Endereço:Centre for Animal Health Innovation, Faculty of Science, Health, Education and Engineering, University of the Sunshine Coast, Sippy Downs, Queensland, Australia.
[Ti] Título:Epidemiology of chlamydial infection and disease in a free-ranging koala (Phascolarctos cinereus) population.
[So] Source:PLoS One;12(12):e0190114, 2017.
[Is] ISSN:1932-6203
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Chlamydial disease continues to be one of the main factors threatening the long-term survival of the koala (Phascolarctos cinereus). Despite this, large epidemiological studies of chlamydial infection and disease in wild koala populations are lacking. A better understanding of the prevalence, transmission and pathogenesis is needed to improve control measures, such as the development of vaccines. We investigated the prevalence of Chlamydia pecorum infection and disease in 160 koalas in a peri-urban wild population in Queensland, Australia and found that 31% of koalas were Chlamydia PCR positive and 28% had clinically detectable chlamydial disease. Most infections were at the urogenital site (27%; both males and females) with only 14% at the ocular site. Interestingly, we found that 27% (4/15) of koalas considered to be sexually immature (9-13 months) were already infected with C. pecorum, suggesting that a significant percentage of animals are infected directly from their mother. Ocular infection levels were less prevalent with increasing age (8% in koalas older than 4 years), whereas the prevalence of urogenital tract infections remained high into older age (26% in koalas older than 4 years), suggesting that, after mother-to-young transmission, C. pecorum is predominantly a sexually transmitted infection. While 28% of koalas in this population had clinically detectable chlamydial disease (primarily urogenital tract disease), many PCR positive koalas had no detectable disease and importantly, not all diseased animals were PCR positive. We also observed higher chlamydial loads in koalas who were C. pecorum infected without clinical disease than in koalas who were C. pecorum infected with clinical disease. These results shed light on the potential mechanisms of transmission of C. pecorum in koalas and also guide future control measures, such as vaccination.
[Mh] Termos MeSH primário: Infecções por Chlamydia/epidemiologia
Chlamydia/isolamento & purificação
Phascolarctidae/microbiologia
[Mh] Termos MeSH secundário: Animais
Feminino
Doenças Urogenitais Femininas/epidemiologia
Doenças Urogenitais Femininas/microbiologia
Masculino
Doenças Urogenitais Masculinas/epidemiologia
Doenças Urogenitais Masculinas/microbiologia
Reação em Cadeia da Polimerase
Prevalência
Queensland/epidemiologia
[Pt] Tipo de publicação:JOURNAL ARTICLE; RESEARCH SUPPORT, NON-U.S. GOV'T
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180206
[Lr] Data última revisão:
180206
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:171228
[St] Status:MEDLINE
[do] DOI:10.1371/journal.pone.0190114


  3 / 1916 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28968886
[Au] Autor:Pearce FA; Craven A; Merkel PA; Luqmani RA; Watts RA
[Ad] Endereço:Division of Epidemiology and Public Health, University of Nottingham.
[Ti] Título:Global ethnic and geographic differences in the clinical presentations of anti-neutrophil cytoplasm antibody-associated vasculitis.
[So] Source:Rheumatology (Oxford);56(11):1962-1969, 2017 Nov 01.
[Is] ISSN:1462-0332
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:Objectives: There are few data on clinical profiles of ANCA-associated vasculitis (AAV) in different ethnic populations. The aim of this study was to examine the differences in the ANCA type and clinical features of AAV between populations using the Diagnostic and Classification Criteria in Vasculitis Study (DCVAS) dataset. Methods: The DCVAS is an international, multicentre, observational study recruiting in 133 sites. Eight ethnic categories were analysed: Northern European, Caucasian American, Southern European, Middle Eastern/Turkish, Chinese, Japanese, Indian subcontinent and other. ANCA type was categorized as myeloperoxidase (MPO), PR3 and ANCA negative. Organ system involvement was recorded using a standard dataset. Differences were analysed by chi-squared tests using a Bonferroni correction and logistic regression (adjusting for age and sex). Northern European was the reference population. Results: Data from 1217 patients with AAV were available and the 967 (79.5%) patients recruited by rheumatology departments were analysed to reduce confounding by recruitment specialty. There were differences in ANCA type between ethnic categories (P < 0.001): MPO-ANCA was more common than PR3-ANCA in Japanese, Chinese and Southern Europeans; PR3-ANCA was more common in the other groups. Compared with Northern Europeans, Japanese had a nearly 60-fold increased chance of having MPO-ANCA (vs PR3-ANCA) [odds ratio (OR) 59.2 (95% CI 8.0, 440.7), P < 0.001] and Chinese had a nearly 7-times increased chance [OR 6.8 (95% CI 2.6, 17.8), P < 0.001]. Ophthalmologic and otorhinolaryngologic involvement were less common in Japanese and Chinese populations than Northern Europeans; otherwise, there were few differences in organ involvement between ethnic groups. Conclusion: This study confirms the previously observed differential occurrence of MPO-AAV and PR3-AAV between different ethnic groups.
[Mh] Termos MeSH primário: Vasculite Associada a Anticorpo Anticitoplasma de Neutrófilos/fisiopatologia
Oftalmopatias/fisiopatologia
Nefropatias/fisiopatologia
Otorrinolaringopatias/fisiopatologia
Dermatopatias/fisiopatologia
[Mh] Termos MeSH secundário: Idoso
Vasculite Associada a Anticorpo Anticitoplasma de Neutrófilos/complicações
Vasculite Associada a Anticorpo Anticitoplasma de Neutrófilos/etnologia
Vasculite Associada a Anticorpo Anticitoplasma de Neutrófilos/imunologia
Anticorpos Anticitoplasma de Neutrófilos/imunologia
Árabes
Grupo com Ancestrais do Continente Asiático
China/epidemiologia
Europa (Continente)/epidemiologia
Grupo com Ancestrais do Continente Europeu
Oftalmopatias/etiologia
Feminino
Doenças Urogenitais Femininas/etiologia
Doenças Urogenitais Femininas/fisiopatologia
Cardiopatias/etiologia
Cardiopatias/fisiopatologia
Seres Humanos
Índia/epidemiologia
Japão/epidemiologia
Nefropatias/etiologia
Masculino
Doenças Urogenitais Masculinas/etiologia
Doenças Urogenitais Masculinas/fisiopatologia
Meia-Idade
Oriente Médio/epidemiologia
Mieloblastina/imunologia
Doenças do Sistema Nervoso/etiologia
Doenças do Sistema Nervoso/fisiopatologia
Razão de Chances
Otorrinolaringopatias/etiologia
Peroxidase/imunologia
Doenças Respiratórias/etiologia
Doenças Respiratórias/fisiopatologia
Dermatopatias/etiologia
Turquia/epidemiologia
Estados Unidos/epidemiologia
[Pt] Tipo de publicação:JOURNAL ARTICLE; OBSERVATIONAL STUDY
[Nm] Nome de substância:
0 (Antibodies, Antineutrophil Cytoplasmic); EC 1.11.1.7 (Peroxidase); EC 3.4.21.76 (Myeloblastin)
[Em] Mês de entrada:1711
[Cu] Atualização por classe:171106
[Lr] Data última revisão:
171106
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:171003
[St] Status:MEDLINE
[do] DOI:10.1093/rheumatology/kex293


  4 / 1916 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
[PMID]:28845949
[Au] Autor:Khryanin AA; Reshetnikov OV
[Ad] Endereço:Novosibirsk State Medical University of Minzdrav of Russia, Novosibirsk, Russia.
[Ti] Título:[The role of mycoplasma infection (M. hominis and U. urealyticum) in inflammatory diseases of the genitourinary system the debate continues].
[So] Source:Urologiia;(3):112-119, 2017 Jul.
[Is] ISSN:1728-2985
[Cp] País de publicação:Russia (Federation)
[La] Idioma:rus
[Ab] Resumo:The article presents current views on urogenital diseases caused by M. hominis and U. urealyticum. Particular attention is paid to concurrent (co-occurring) urogenital infections. The review reports the data from epidemiological studies and outlines recent Russian and international guidelines and consensuses on managing patients with urogenital inflammatory diseases. The importance of adequate diagnosis and rational therapy of urogenital infections is discussed.
[Mh] Termos MeSH primário: Doenças Urogenitais Femininas/microbiologia
Doenças Urogenitais Masculinas/microbiologia
Infecções por Mycoplasma/complicações
Mycoplasma hominis/patogenicidade
Infecções por Ureaplasma/complicações
Ureaplasma urealyticum/patogenicidade
[Mh] Termos MeSH secundário: Feminino
Seres Humanos
Masculino
Mycoplasma hominis/isolamento & purificação
Ureaplasma urealyticum/isolamento & purificação
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Em] Mês de entrada:1711
[Cu] Atualização por classe:171109
[Lr] Data última revisão:
171109
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170829
[St] Status:MEDLINE


  5 / 1916 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28800835
[Au] Autor:Wilson C; Corrigan R; Braun L
[Ad] Endereço:Acupuncture and Integrative Medicine Center, Malcolm Grow Medical Clinics and Surgery Center, Joint Base Andrews, MD. Electronic address: candy.wilson@usuhs.edu.
[Ti] Título:Deployed women's illness behaviors while managing genitourinary symptoms: An exploratory theoretical synthesis of two qualitative studies.
[So] Source:Nurs Outlook;65(5S):S17-S25, 2017 Sep - Oct.
[Is] ISSN:1528-3968
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: The recent removal of United States military combat exclusion rules resulted in more women serving in forward deployed austere conditions. In the deployed setting, women were diagnosed with genitourinary (GU) conditions five times greater than men. PURPOSE: Describe deployed military women's GU illness behaviors. METHOD: Two qualitative descriptive studies interviewing military women and enlisted medics were synthesized using the Illness Behavior Model. DISCUSSION: Similar and divergent views on the impact of the military culture of the illness behaviors were described by women and medics. Both agreed appropriate attention on managing GU symptoms must continue; however differing strategies were appraised. One agreed option was to offer a health care mentor. CONCLUSION: The Illness Behavior Model provided an excellent framework for evaluation of military women's illness behaviors exposing areas for comparing and contrasting the perspectives provided. While significant changes have been made, additional strategies will continue to improve the women's deployed health care quality.
[Mh] Termos MeSH primário: Doenças Urogenitais Femininas/psicologia
Comportamento de Doença
Militares
[Mh] Termos MeSH secundário: Adaptação Psicológica
Adulto
Feminino
Doenças Urogenitais Femininas/complicações
Doenças Urogenitais Femininas/terapia
Seres Humanos
Modelos Teóricos
Aceitação pelo Paciente de Cuidados de Saúde
Pesquisa Qualitativa
Autocuidado
Estados Unidos
Exposição à Guerra
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1711
[Cu] Atualização por classe:171113
[Lr] Data última revisão:
171113
[Sb] Subgrupo de revista:AIM; IM; N
[Da] Data de entrada para processamento:170813
[St] Status:MEDLINE


  6 / 1916 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28697116
[Au] Autor:Mahnert N; Kamdar N; Lim CS; Skinner B; Hassett A; Kocher KE; Morgan DM; As-Sanie S
[Ad] Endereço:Department of Obstetrics and Gynecology, Banner University Medical Center, University of Arizona, Phoenix, Arizona; and the Departments of Obstetrics and Gynecology, Anesthesiology, and Emergency Medicine and the Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan.
[Ti] Título:Risk Factors for Emergency Department Visits After Hysterectomy for Benign Disease.
[So] Source:Obstet Gynecol;130(2):296-304, 2017 Aug.
[Is] ISSN:1873-233X
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:OBJECTIVE: To identify the incidence, indications, and risk factors for emergency department visits that do not result in readmission within 30 days of hysterectomy for benign disease. METHODS: We conducted a secondary data analysis of hysterectomies for benign disease using the Michigan Surgical Quality Collaborative, a statewide group of hospitals that voluntarily reports perioperative outcomes. Hysterectomies for benign disease were abstracted from January 1, 2013, to July 2, 2014. We examined the incidence of emergency department visits within 30 days after hysterectomy for benign disease and constructed a multivariable logistic regression model to identify risk factors for these visits. We focused on emergency department visits that did not result in readmission because they are more likely to represent avoidable encounters. RESULTS: Among the 10,274 women who underwent hysterectomy for benign disease during the study period, 932 (9.1%) presented to the emergency department and were not readmitted to the hospital. Based on a multivariable regression model, risk factors for emergency department visits after hysterectomy for benign disease were younger age, higher parity, Medicaid or self-pay insurance, prior venous thromboembolism, chronic obstructive pulmonary disease, preoperative surgical indication of chronic pelvic pain, and postoperative day 1 pain scores greater than 4 on a 0-10 numeric rating scale. The most common primary emergency department International Classification of Diseases, 9th Revision diagnoses were for pain (29.5% [n=275]), gastrointestinal (12.8% [n=118]), and genitourinary (10.7% [n=99]) complaints. CONCLUSION: Approximately 1 in 11 women present to the emergency department, but do not result in readmission within 30 days of hysterectomy for benign disease. Emergency department visits might be avoided with expanded perioperative education and improved communication pathways for high-risk patients.
[Mh] Termos MeSH primário: Serviço Hospitalar de Emergência/estatística & dados numéricos
Histerectomia/efeitos adversos
Complicações Pós-Operatórias/terapia
Doenças Uterinas/cirurgia
[Mh] Termos MeSH secundário: Adulto
Fatores Etários
Feminino
Doenças Urogenitais Femininas
Gastroenteropatias
Seres Humanos
Meia-Idade
Medição da Dor
Educação de Pacientes como Assunto
Readmissão do Paciente/estatística & dados numéricos
Dor Pélvica
Fatores de Risco
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1708
[Cu] Atualização por classe:170821
[Lr] Data última revisão:
170821
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170712
[St] Status:MEDLINE
[do] DOI:10.1097/AOG.0000000000002146


  7 / 1916 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28578175
[Au] Autor:Katon JG; Gray K; Callegari L; Gardella C; Gibson C; Ma E; Lynch KE; Zephyrin L
[Ad] Endereço:Health Services Research and Development Center of Innovation for Veteran-Centered and Value Driven Care, US Department of Veterans Affairs, Veterans Affairs Puget Sound Healthcare System, Seattle, WA; Department of Health Services, University of Washington School of Public Health, Seattle, WA. Elec
[Ti] Título:Trends in hysterectomy rates among women veterans in the US Department of Veterans Affairs.
[So] Source:Am J Obstet Gynecol;217(4):428.e1-428.e11, 2017 Oct.
[Is] ISSN:1097-6868
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: Prior studies demonstrate a higher prevalence of hysterectomy among veterans compared with nonveterans. While studies identify overall decreasing hysterectomy rates in the United States, none report rates of hysterectomy among women veterans. Given the increasing numbers of women veterans using Veterans Affairs health care, there is an ongoing need to ensure high-quality gynecology care. Therefore, it is important to examine current hysterectomy trends, including proportion of minimally invasive surgeries, among veterans using Veterans Affairs health care. OBJECTIVE: Our objective was to describe hysterectomy trends and utilization of minimally invasive hysterectomy in the Veterans Affairs healthcare system. STUDY DESIGN: This longitudinal study used Veterans Affairs clinical and administrative data from fiscal year 2008 to 2014 to identify hysterectomies provided or paid for by Veterans Affairs. Crude and age-adjusted hysterectomy rates were calculated by indication (benign or malignant), mode (abdominal, laparoscopic, vaginal, robotic assisted, unspecified), and source of care (provided vs paid for by Veterans Affairs). Mode and indication for hysterectomy were classified using International Classification of Diseases, ninth revision, codes. The distribution of hysterectomy mode in each year was calculated by indication and source of care. RESULTS: Between fiscal year 2008 and fiscal year 2014, the total hysterectomy rate decreased from 4.0 per 1000 to 2.6 per 1000 unique women veteran Veterans Affairs users. Age-adjusted rates of abdominal hysterectomy for benign indications decreased over the study period from 1.54 per 1000 (95% confidence interval, 1.40-1.69) to 0.77 per 1000 (95% confidence interval, 0.69-0.85) for procedures provided by Veterans Affairs and 0.77 per 1,000 (95% confidence interval, 0.69-0.85) to 0.29 per 1,000 (95% confidence interval, 0.23-0.34) for those paid for by Veterans Affairs. Among hysterectomies for benign indications provided by (n = 5296) or paid for (n = 2610) by Veterans Affairs, the percentage of hysterectomies performed abdominally decreased from 67.2% to 46.8% and from 68.9% to 57.6%, respectively. CONCLUSION: These findings suggest that gynecology care provided within Veterans Affairs has kept pace with national trends in reducing hysterectomy rates and increasing utilization of minimally invasive surgical techniques.
[Mh] Termos MeSH primário: Histerectomia/tendências
Veteranos
[Mh] Termos MeSH secundário: Adolescente
Adulto
Distribuição por Idade
Idoso
Dismenorreia/cirurgia
Feminino
Doenças Urogenitais Femininas/cirurgia
Seres Humanos
Histerectomia/métodos
Laparoscopia/tendências
Estudos Longitudinais
Meia-Idade
Procedimentos Cirúrgicos Robóticos/tendências
Estados Unidos/epidemiologia
United States Department of Veterans Affairs
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171002
[Lr] Data última revisão:
171002
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170605
[St] Status:MEDLINE


  8 / 1916 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28427377
[Au] Autor:den Heijer CDJ; Hoebe CJPA; van Liere GAFS; van Bergen JEAM; Cals JWL; Stals FS; Dukers-Muijrers NHTM
[Ad] Endereço:Department of Medical Microbiology, Maastricht University Medical Centre, CAPHRI School of Public Health and Primary Care, Maastricht, the Netherlands. casper.denheijer@ggdzl.nl.
[Ti] Título:A comprehensive overview of urogenital, anorectal and oropharyngeal Neisseria gonorrhoeae testing and diagnoses among different STI care providers: a cross-sectional study.
[So] Source:BMC Infect Dis;17(1):290, 2017 Apr 20.
[Is] ISSN:1471-2334
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: Gonorrhoea, caused by Neisseria gonorrhoeae (NG), can cause reproductive morbidity, is increasingly becoming resistant to antibiotics and is frequently asymptomatic, which shows the essential role of NG test practice. In this study we wanted to compare NG diagnostic testing procedures between different STI care providers serving a defined geographic Dutch region (280,000 inhabitants). METHODS: Data on laboratory testing and diagnosis of urogenital and extragenital (i.e. anorectal and oropharyngeal) NG were retrieved from general practitioners (GPs), an STI clinic, and gynaecologists (2006-2010). Per provider, we assessed their contribution regarding the total number of tests performed and type of populations tested, the proportion of NG positives re-tested (3-12 months after treatment) and test-of-cure (TOC, within 3 months post treatment). RESULTS: Overall, 17,702 NG tests (48.7% STI clinic, 38.2% GPs, 13.1% gynaecologists) were performed during 15,458 patient visits. From this total number of tests, 2257 (12.7%) were extragenital, of which 99.4% were performed by the STI clinic. Men were mostly tested at the STI clinic (71%) and women by their GP (43%). NG positivity per visit was 1.6%; GP 1.9% (n = 111), STI clinic 1.7% (n = 131) and gynaecology 0.2% (n = 5). NG positivity was associated with Chlamydia trachomatis positivity (OR: 2.06, 95% confidence interval: 1.46-2.92). Per anatomical location, the proportion of NG positives re-tested were: urogenital 20.3% (n = 36), anorectal 43.6% (n = 17) and oropharyngeal 57.1% (n = 20). NG positivity among re-tests was 16.9%. Proportions of NG positives with TOC by anatomical location were: urogenital 10.2% (n = 18), anorectal 17.9% (n = 7) and oropharyngeal 17.1% (n = 6). CONCLUSIONS: To achieve best practice in relation to NG testing, we recommend that: 1) GPs test at extragenital sites, especially men who have sex with men (MSM), 2) all care providers consider re-testing 3 to 12 months after NG diagnosis and 3) TOC is performed following oropharyngeal NG diagnosis in settings which provide services to higher-risk men and women (such as STI clinics).
[Mh] Termos MeSH primário: Gonorreia/diagnóstico
Doenças Faríngeas/microbiologia
[Mh] Termos MeSH secundário: Adulto
Instituições de Assistência Ambulatorial/estatística & dados numéricos
Infecções por Chlamydia/diagnóstico
Chlamydia trachomatis/patogenicidade
Estudos Transversais
Feminino
Doenças Urogenitais Femininas/diagnóstico
Doenças Urogenitais Femininas/microbiologia
Clínicos Gerais
Gonorreia/epidemiologia
Seres Humanos
Masculino
Doenças Urogenitais Masculinas/diagnóstico
Doenças Urogenitais Masculinas/microbiologia
Neisseria gonorrhoeae/isolamento & purificação
Neisseria gonorrhoeae/patogenicidade
Países Baixos/epidemiologia
Doenças Faríngeas/diagnóstico
Médicos
Doenças Retais/diagnóstico
Doenças Retais/microbiologia
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1708
[Cu] Atualização por classe:170807
[Lr] Data última revisão:
170807
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170422
[St] Status:MEDLINE
[do] DOI:10.1186/s12879-017-2402-0


  9 / 1916 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28384829
[Au] Autor:Jin J
[Ti] Título:Vaginal and Urinary Symptoms of Menopause.
[So] Source:JAMA;317(13):1388, 2017 04 04.
[Is] ISSN:1538-3598
[Cp] País de publicação:United States
[La] Idioma:eng
[Mh] Termos MeSH primário: Menopausa
Vagina/patologia
[Mh] Termos MeSH secundário: Atrofia
Feminino
Doenças Urogenitais Femininas/etiologia
Doenças Urogenitais Femininas/terapia
Seres Humanos
Meia-Idade
Incontinência Urinária
[Pt] Tipo de publicação:PATIENT EDUCATION HANDOUT
[Em] Mês de entrada:1706
[Cu] Atualização por classe:170606
[Lr] Data última revisão:
170606
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170407
[St] Status:MEDLINE
[do] DOI:10.1001/jama.2017.0833


  10 / 1916 MEDLINE  
              first record previous record
seleciona
para imprimir
Fotocópia
[PMID]:28333902
[Au] Autor:Kaminsky V; Chernyshov V; Grynevych O; Benyuk V; Kornatskaya A; Shalko M; Usevich I; Revenko O; Shepetko M; Solomakha L
[Ad] Endereço:Shupyk National Medical Academy for Post-graduate Education, Kyiv, Ukraine.
[Ti] Título:Proteflazid® and local immunity in diseases caused by human papillomavirus, herpesvirus and mixed urogenital infections.
[So] Source:Pol Merkur Lekarski;42(249):110-115, 2017 Mar 21.
[Is] ISSN:1426-9686
[Cp] País de publicação:Poland
[La] Idioma:eng
[Ab] Resumo:Reporting of clinical trials results for Proteflazid® in the drug formulation suppositories and vaginal swabs soaked in the solution of the drug to the local immunity of the female reproductive tract. AIM: The aim of study was to examine the state of local immunity in the reproductive tract of women with sexually transmitted diseases caused by human papillomavirus, herpes viruses (Type 1, 2) and mixed infection (herpes viruses + chlamydia). MATERIALS AND METHODS: The trials involved 216 women with viral sexually transmitted diseases: Cervical Dysplasia associated with papillomavirus infection (HPV) (Group 1); Herpes genitalis type 1 (HSV- 1) and type 2 (HSV-1) (Group 2); mixed infection - HSV-1, HSV-2 and chlamydia (Group 3). RESULTS: Treatment results have confirmed that Proteflazid® contributes to sustainable performance improvement of basic factors of local immunity - sIgA, lysozyme and complement component C3 in the cervical mucus for all three groups of women. CONCLUSIONS: Proteflazid® enhances level of local immunity markers (sIgA, lysozyme, C3 complement component) and improves their ratios. Also it intensifies anticontagious activity of mucosal protection and female reproductive system as whole, during treatment diseases caused by human papillomavirus, herpesvirus and mixed urogenital infections (herpesvirus and chlamydia).
[Mh] Termos MeSH primário: Infecções por Chlamydia/tratamento farmacológico
Coinfecção/tratamento farmacológico
Infecções por Herpesviridae/tratamento farmacológico
Sistema Imunitário/efeitos dos fármacos
Infecções por Papillomavirus/tratamento farmacológico
Extratos Vegetais/uso terapêutico
Doenças Sexualmente Transmissíveis/tratamento farmacológico
[Mh] Termos MeSH secundário: Coinfecção/microbiologia
Coinfecção/virologia
Feminino
Doenças Urogenitais Femininas/tratamento farmacológico
Doenças Urogenitais Femininas/microbiologia
Doenças Urogenitais Femininas/virologia
Herpesvirus Humano 1/efeitos dos fármacos
Herpesvirus Humano 2/efeitos dos fármacos
Seres Humanos
Papillomaviridae/efeitos dos fármacos
Extratos Vegetais/farmacologia
Plantas Medicinais
Poaceae
Doenças Sexualmente Transmissíveis/microbiologia
Doenças Sexualmente Transmissíveis/virologia
Resultado do Tratamento
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Plant Extracts)
[Em] Mês de entrada:1707
[Cu] Atualização por classe:170707
[Lr] Data última revisão:
170707
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170324
[St] Status:MEDLINE



página 1 de 192 ir para página                         
   


Refinar a pesquisa
  Base de dados : MEDLINE Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde